Kenneth V. Lieberman

1.6k total citations
38 papers, 989 citations indexed

About

Kenneth V. Lieberman is a scholar working on Nephrology, Epidemiology and Transplantation. According to data from OpenAlex, Kenneth V. Lieberman has authored 38 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 8 papers in Epidemiology and 7 papers in Transplantation. Recurrent topics in Kenneth V. Lieberman's work include Renal Diseases and Glomerulopathies (11 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Complement system in diseases (5 papers). Kenneth V. Lieberman is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Complement system in diseases (5 papers). Kenneth V. Lieberman collaborates with scholars based in United States, Italy and United Kingdom. Kenneth V. Lieberman's co-authors include Amir Tejani, Lewis Reisman, L Burrows, Harry Schanzer, Isabel Roberti, Silvio Maringhini, Lesley Rees, Lars Pape, Johan Vande Walle and Samhar Al‐Akash and has published in prestigious journals such as Blood, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Kenneth V. Lieberman

36 papers receiving 949 citations

Peers

Countries citing papers authored by Kenneth V. Lieberman

Since Specialization

Citations

This map shows the geographic impact of Kenneth V. Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth V. Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth V. Lieberman more than expected).

Fields of papers citing papers by Kenneth V. Lieberman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth V. Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth V. Lieberman. The network helps show where Kenneth V. Lieberman may publish in the future.

Co-authorship network of co-authors of Kenneth V. Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth V. Lieberman. A scholar is included among the top collaborators of Kenneth V. Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth V. Lieberman. Kenneth V. Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	COL4A gene variants are common in children with hematuria and a family history of kidney disease 2023 ·Pediatric Nephrology ·Michelle N. Rheault, Heather M. McLaughlin, (unknown), Lauren E. Blake, Prasad Devarajan, Bradley A. Warady, Keisha L. Gibson, Kenneth V. Lieberman	5
2	CMV‐associated collapsing focal segmental glomerulosclerosis after kidney transplant in a pediatric patient 2023 ·Pediatric Transplantation ·(unknown), Guillermo Hidalgo, Michael J. Goldstein, Ibrahim Batal, Kenneth V. Lieberman, (unknown), (unknown), Namrata G. Jain	0
3	The KIDNEYCODE Program: Diagnostic Yield and Clinical Features of Individuals with CKD 2022 ·Kidney360 ·Kenneth V. Lieberman, Alex R. Chang, Geoffrey A. Block, (unknown), Sara L. Bristow, Ana Morales, (unknown), (unknown), (unknown), Martin R. Pollak, Swaroop Aradhya, Bradley A. Warady	7
4	DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS 2018 ·Journal of the American Society of Nephrology ·Howard Trachtman, Peter J. Nelson, Sharon G. Adler, Kirk N. Campbell, Abanti Chaudhuri, Vimal K. Derebail, Giovanni Gambaro, Loreto Gesualdo, Debbie S. Gipson, Jonathan Hogan, Kenneth V. Lieberman, Brad A. Marder, Kevin Meyers, (unknown), Jai Radhakrishnan, Tarak Srivastava, (unknown), Vladimı́r Tesař, Olga Zhdanova, Radko Komers, (unknown)	129
5	Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance 2016 ·Journal of Nephrology ·Kenneth V. Lieberman, (unknown)	15
6	Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease 2016 ·The American Journal of Human Genetics ·Dongchuan Guo, (unknown), Ellen S. Regalado, (unknown), Callie Kwartler, Dong Kim, Kenneth V. Lieberman, Bert B.A. de Vries, Rolph Pfundt, Albert Schinzel, Dieter Kotzot, (unknown), (unknown), Michael J. Bamshad, Deborah A. Nickerson, Heather L. Gornik, Santhi K. Ganesh, Alan C. Braverman, Dorothy K. Grange, Dianna M. Milewicz	45
7	Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome 2016 ·Kidney International ·Larry A. Greenbaum, Marc Fila, Gianluigi Ardissino, Samhar Al‐Akash, Jonathan Evans, Paul Henning, Kenneth V. Lieberman, Silvio Maringhini, Lars Pape, Lesley Rees, Nicole C. A. J. van de Kar, Johan Vande Walle, Masayo Ogawa, Camille L. Bedrosian, Christoph Licht	198
8	A prospective study of paediatric patients with atypical haemolytic uraemic syndrom (aHUS) treated with eculuzumab : 1- year update 2015 ·Pediatric Nephrology ·(unknown), Larry A. Greenbaum, Marc Fila, (unknown), Samhar Al‐Akash, Jonathan Evans, Kenneth V. Lieberman, Silvio Maringhini, Lars Pape, Nicole C. A. J. van de Kar, Johan Vande Walle, Masayo Ogawa, Camille L. Bedrosian, (unknown)	2
9	Eculizumab Inhibits Thrombotic Microangiopathy and Improves Renal Function in Pediatric Patients with Atypical Hemolytic Uremic Syndrome: 1-Year Update 2014 ·Blood ·Laurence Greenbaum, Marc Fila, Gianluigi Ardissino, Samhar Al‐Akash, Jonathan HC Evans, Kenneth V. Lieberman, Silvio Maringhini, Lars Pape, Lesley Rees, Nicole C. A. J. van de Kar, Johan Vande Walle, Masayo Ogawa, Camille L. Bedrosian, Christoph Licht	2
10	Eculizumab Inhibits Thrombotic Microangiopathy and Improves Renal Function in Pediatric Patients With Atypical Hemolytic Uremic Syndrome 2013 ·Ghent University Academic Bibliography (Ghent University) ·Larry A. Greenbaum, Marc Fila, Michel Tsimaratos, (unknown), Samhar Al‐Akash, Jonathan Evans, Paul Henning, Kenneth V. Lieberman, Silvio Maringhini, Lars Pape, Lesley Rees, Nicole C. A. J. van de Kar, Johan Vande Walle, Masayo Ogawa, Camille L. Bedrosian, Christoph Licht	1
11	The Efficacy and Safety of Valsartan in Obese and Non-Obese Pediatric Hypertensive Patients 2011 ·Journal of Clinical Hypertension ·Kevin Meyers, Kenneth V. Lieberman, Susan Solar‐Yohay, (unknown), Victor Shi	11
12	A new case of Grange syndrome without cardiac findings 2006 ·American Journal of Medical Genetics Part A ·Robert Wallerstein, (unknown), (unknown), (unknown), (unknown), (unknown), Kenneth V. Lieberman	10
13	Comparative value of urinalysis, urine cytology and urine sIL2R in the assessment of renal disease in patients with systemic lupus erythematosus (SLE). 1996 ·PubMed ·Isabel Roberti, Steven Dikman, Harry Spiera, Lewis Reisman, (unknown), Kenneth V. Lieberman	9
14	IgA nephritis in a child with human immunodeficiency virus: a unique form of human immunodeficiency virus-associated nephropathy? 1992 ·Pediatric Nephrology ·Morris J. Schoeneman, V. S. Ghali, Kenneth V. Lieberman, Lewis Reisman	10
15	EVIDENCE THAT THE SYSTEMATIC ANALYSIS OF BILE CYTOLOGY PERMITS MONITORING OF HEPATIC ALLOGRAFT REJECTION 1992 ·Transplantation ·Isabel Roberti, Kenneth V. Lieberman, Cosme Manzarbeitia, Myron Schwartz, Lewis Reisman, Charles M. Miller	6
16	Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course. 1990 ·PubMed ·V.S. Venkataseshan, Kenneth V. Lieberman, (unknown), Swan N. Thung, Steven Dikman, Vivette D. D’Agati, Myron Susin, Elsa Valderrama, Bernard Gauthier, Atul Prakash	60
17	Characteristics of social networks in adolescents with end-stage renal disease treated with renal transplantation 1989 ·Journal of Adolescent Health Care ·Sanford M. Melzer, Bonnie J. Leadbeater, Lewis Reisman, (unknown), Kenneth V. Lieberman	18
18	Immunopharmacodynamic Profiles in Children With Renal Allografts Receiving Cyclosporine Therapy 1988 ·American Journal of Kidney Diseases ·Lewis Reisman, Kenneth V. Lieberman, Giorgio P. Martinelli, Kristian M. Bowles, Harry Schanzer, L Burrows	6
19	Continuous arteriovenous hemofiltration in children 1987 ·Pediatric Nephrology ·Kenneth V. Lieberman	34
20	Treatment of acute renal failure in an infant using continuous arteriovenous hemofiltration 1985 ·The Journal of Pediatrics ·Kenneth V. Lieberman, (unknown), Juan P. Bosch	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact